Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Operating Expenses (2010 - 2026)

Updated

Iovance Biotherapeutics (IOVA) reported Operating Expenses of $151.22 million for Q2 2026, down 13.0% from $173.73 million a year earlier and down 0.8% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Iovance Biotherapeutics' Operating Expenses came in at $626.28 million, down 4.0% year-over-year; for FY2025, it was $666.86 million, up 19.2% from FY2024.

  • Operating Expenses has increased for 11 consecutive years, with a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $559.35 million in FY2024 (+21.1%), $461.75 million in FY2023 (+15.8%), $398.88 million in FY2022 (+16.4%) and $342.7 million in FY2021 (+30.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Operating Expenses since Q3 2024.
  • Year over year, Operating Expenses gained in five of the last eight quarters, with growth averaging 14.6%.
  • The high point for year-over-year Operating Expenses in five years was Q3 2021 (growth of 46.3%); the low point was Q2 2026 (a decline of 13.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $152.47 million (Q1 2026), $160.23 million (Q4 2025) and $162.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 151.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 151.22 Mn
Mar 31, 2026 152.47 Mn
Dec 31, 2025 160.23 Mn
Sep 30, 2025 162.36 Mn
Jun 30, 2025 173.73 Mn
Mar 31, 2025 170.55 Mn
Dec 31, 2024 160.27 Mn
Sep 30, 2024 147.62 Mn
Jun 30, 2024 133.02 Mn
Mar 31, 2024 118.44 Mn
Dec 31, 2023 121.74 Mn
Sep 30, 2023 118.83 Mn
Jun 30, 2023 110.32 Mn
Mar 31, 2023 110.86 Mn
Dec 31, 2022 107.04 Mn
Sep 30, 2022 100.40 Mn
Jun 30, 2022 99.73 Mn
Mar 31, 2022 91.71 Mn
Dec 31, 2021 99.47 Mn
Sep 30, 2021 86.24 Mn
API Access

Iovance Biotherapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY